Pre-discharge 18F-Flourodeoxyglucose uptake pattern following transcatheter aortic-valve replacement and adverse prognostic features in aortic stenosis

Indian Heart J. 2023 Sep-Oct;75(5):386-389. doi: 10.1016/j.ihj.2023.08.002. Epub 2023 Aug 9.

Abstract

18F-Flourodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) has been shown to be of utility in transcatheter aortic valve replacement (TAVR) patients with suspected prosthetic valve endocarditis. In the present study, we sought to analyze the relationship between 18F-FDG-PET/CT performed before discharge in TAVR patients and adverse prognostic features of aortic stenosis. We analyzed the association between 18F-FDG-PET/CT uptake pattern and degree of left ventricular mass index, aortic root dilatation, and aortic leaflet calcification extent. This is the first study to demonstrate that pre-discharge 18F-FDG-PET/CT in patients undergoing TAVR shows a significant negative correlation between 18F-FDG uptake pattern and adverse prognostic features.

Keywords: 18F-flourodeoxyglucose; Aortic stenosis; Aortic valve replacement.

MeSH terms

  • Aortic Valve / diagnostic imaging
  • Aortic Valve / surgery
  • Aortic Valve Stenosis* / diagnosis
  • Aortic Valve Stenosis* / surgery
  • Endocarditis, Bacterial*
  • Fluorodeoxyglucose F18 / pharmacology
  • Heart Valve Prosthesis*
  • Humans
  • Patient Discharge
  • Positron Emission Tomography Computed Tomography / methods
  • Prognosis
  • Radiopharmaceuticals / pharmacology
  • Transcatheter Aortic Valve Replacement*
  • Treatment Outcome

Substances

  • Fluorodeoxyglucose F18
  • Radiopharmaceuticals